Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Current Molecular Imaging
|
May 30, 2015
FLIM-FRET for Cancer Applications
Shilpi Rajoria, Lingling Zhao, Xavier Intes, et al.
Biomedical Optics Express
|
April 2, 2014
Spatial light modulator based active wide-field illumination for ex vivo and in vivo quantitative NIR FRET imaging
Lingling Zhao, Ken Abe, Shilpi Rajoria, et al.
Molecular Cancer
|
October 24, 2012
Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence
Andrea L George, Shilpi Rajoria, Robert Suriano, et al.
Plos One
|
February 25, 2012
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
Arulkumaran Shanmugam, Shilpi Rajoria, Andrea L George, et al.
Journal of Cancer
|
July 9, 2013
Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines
Robert Suriano, Shilpi Rajoria, Andrea L George, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma
Robert Suriano, Shilpi Rajoria, Andrea L George, et al.
Redox Biology
|
September 1, 2020
Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors
Ting Chean Khoo, Kate Tubbesing, Alena Rudkouskaya, et al.
Peptides
|
May 5, 2011
Identification of PSA peptide mimotopes using phage display peptide library
Arulkumaran Shanmugam, Robert Suriano, Devyani Chaudhuri, et al.
Plos One
|
January 27, 2011
Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer
Shilpi Rajoria, Robert Suriano, Andrea George, et al.
Oncology Reports
|
December 15, 2010
3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways
Shilpi Rajoria, Robert Suriano, Yushan Lisa Wilson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Current Molecular Imaging
|
May 30, 2015
FLIM-FRET for Cancer Applications
Shilpi Rajoria, Lingling Zhao, Xavier Intes, et al.
Biomedical Optics Express
|
April 2, 2014
Spatial light modulator based active wide-field illumination for ex vivo and in vivo quantitative NIR FRET imaging
Lingling Zhao, Ken Abe, Shilpi Rajoria, et al.
Molecular Cancer
|
October 24, 2012
Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence
Andrea L George, Shilpi Rajoria, Robert Suriano, et al.
Plos One
|
February 25, 2012
Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants
Arulkumaran Shanmugam, Shilpi Rajoria, Andrea L George, et al.
Journal of Cancer
|
July 9, 2013
Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines
Robert Suriano, Shilpi Rajoria, Andrea L George, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma
Robert Suriano, Shilpi Rajoria, Andrea L George, et al.
Redox Biology
|
September 1, 2020
Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors
Ting Chean Khoo, Kate Tubbesing, Alena Rudkouskaya, et al.
Peptides
|
May 5, 2011
Identification of PSA peptide mimotopes using phage display peptide library
Arulkumaran Shanmugam, Robert Suriano, Devyani Chaudhuri, et al.
Plos One
|
January 27, 2011
Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer
Shilpi Rajoria, Robert Suriano, Andrea George, et al.
Oncology Reports
|
December 15, 2010
3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways
Shilpi Rajoria, Robert Suriano, Yushan Lisa Wilson, et al.
Page
of 2